Sacks B, Smith S
Department of Psychiatry, Charing Cross and Westminster Medical School, London.
J Neurol Neurosurg Psychiatry. 1989 Nov;52(11):1294-5. doi: 10.1136/jnnp.52.11.1294.
The mydriatic response to eyedrops of the anticholinergic agent tropicamide at very low concentration (0.01%) has been studied in people with Down's syndrome. By comparison with healthy subjects people with Down's syndrome had responses approximately three times greater, suggesting a peripheral imbalance between cholinergic and adrenergic autonomic influences.
对唐氏综合征患者使用极低浓度(0.01%)的抗胆碱能药物托吡卡胺滴眼液后的散瞳反应进行了研究。与健康受试者相比,唐氏综合征患者的反应大约大三倍,这表明胆碱能和肾上腺素能自主神经影响之间存在外周失衡。